Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123M
-
Number of holders
-
136
-
Total 13F shares, excl. options
-
64.7M
-
Shares change
-
-1.09M
-
Total reported value, excl. options
-
$299M
-
Value change
-
-$3M
-
Put/Call ratio
-
0.1
-
Number of buys
-
62
-
Number of sells
-
-60
-
Price
-
$4.62
Significant Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q2 2020
158 filings reported holding CPRX - CATALYST PHARMACEUTICALS, INC. - COMMON STOCK as of Q2 2020.
CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) has 136 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64.7M shares
of 123M outstanding shares and own 52.53% of the company stock.
Largest 10 shareholders include BlackRock Inc. (7.64M shares), STATE STREET CORP (6.68M shares), ARMISTICE CAPITAL, LLC (6.2M shares), VANGUARD GROUP INC (5.09M shares), MANGROVE PARTNERS (3.13M shares), MORGAN STANLEY (2.82M shares), GOLDMAN SACHS GROUP INC (2.07M shares), SCHRODER INVESTMENT MANAGEMENT GROUP (1.65M shares), GEODE CAPITAL MANAGEMENT, LLC (1.57M shares), and PRUDENTIAL FINANCIAL INC (1.42M shares).
This table shows the top 136 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.